Matches in Nanopublications for { ?s ?p "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP298585.RAC0InswdSIqu_U6K4VYgcLedJWDM5ZpY197QNBaDr4wg130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298585.RAC0InswdSIqu_U6K4VYgcLedJWDM5ZpY197QNBaDr4wg130_provenance.
- NP298427.RAqGx5PUiYYzkObIqB4srk2UIu_LLzAULmIebzfgsCIQA130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298427.RAqGx5PUiYYzkObIqB4srk2UIu_LLzAULmIebzfgsCIQA130_provenance.
- NP302184.RAn5z92QBfe36_71NV36BHJYXs7BnK2zWeTfrvS8LcVUQ130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302184.RAn5z92QBfe36_71NV36BHJYXs7BnK2zWeTfrvS8LcVUQ130_provenance.
- NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633216.RApHvFjHfur2lFcl32vTTmXGOPImSAtG2Y6GlC8jBVoHU130_provenance.
- NP302044.RA6FKSmfOMiJzZsg66DBwbKYdmKY13nCX6fRdX9Mn0r9I130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302044.RA6FKSmfOMiJzZsg66DBwbKYdmKY13nCX6fRdX9Mn0r9I130_provenance.
- NP302065.RA0S9wbsPEBKHmEVZiaYozHRBaF6TwYvumXI14fq-578Q130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302065.RA0S9wbsPEBKHmEVZiaYozHRBaF6TwYvumXI14fq-578Q130_provenance.
- NP302122.RA68pw5syz5TzTvWuf3BjcRCI9gToeGfV02tTHOKQHvfU130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302122.RA68pw5syz5TzTvWuf3BjcRCI9gToeGfV02tTHOKQHvfU130_provenance.
- NP633332.RAMWMeHohEcQrMY_ARc92JM43UOKaLLou0huzYqHaUEcw130_assertion description "[Cdk9 and Cdk7 are cdc2-like serine/threonine kinases that stabilize RNA transcript elongation through RNA polII carboxyl terminal domain (CTD) phosphorylation and are considered suitable targets for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633332.RAMWMeHohEcQrMY_ARc92JM43UOKaLLou0huzYqHaUEcw130_provenance.